Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.

Marc Better(XOMA (United States)), Arnold H. Horwitz(XOMA (United States)), Stephen F. Carroll(IGM Biosciences (United States)), Shau-Ping Lei(XOMA (United States)), Susan L. Bernhard(XOMA (United States)), Julie A. Lane(Amgen (United States)), Dianne M. Fishwild(XOMA (United States))
Proceedings of the National Academy of Sciences
January 15, 1993
Cited by 48


Related Papers